For Immediate Release: September 6, 2016

AtlantiCare Neurosciences Institute to host
sixth annual Regional Neurosciences Conference and Stroke Summit

Who:            More than 300 healthcare providers

What:          To attend AtlantiCare Neurosciences Institute's sixth annual Regional Neurosciences Conference and State of the Art Stroke Summit

When:          Thursday, September 8, 7:45 a.m. to 4:45 p.m.
                    Friday, September 9, 7 a.m. to 12:30 p.m.
                    (Media interested in covering the event should call Jennifer Tornetta at 609-569-7010 or 609-335-3446.)

Where:        Golden Nugget® Atlantic City, New Jersey
                    600 Huron Avenue & Brigantine Boulevard

Details:       The AtlantiCare Neurosciences Institute will host its sixth annual Regional Neurosciences Conference and State of the Art Stroke Summit Thursday, September 8 and Friday, September 9 at the Golden Nugget Atlantic City. More than 300 healthcare providers, including physicians, nurses, allied health providers, pharmacists, rehabilitation therapists, social workers, case managers, radiology technologists and first responders have registered to attend the event – which will focus on prevention, diagnosis and treatment of stroke and other neurological and neurosurgical disorders.

Experts from AtlantiCare Regional Medical Center; Jefferson Neurosurgical Associates at AtlantiCare; Rothman Institute at AtlantiCare; Geisinger Health System; Thomas Jefferson University Hospital and Sidney Kimmel Medical School; Children's Hospital of Philadelphia Newborn and Pediatric Care at AtlantiCare; and Temple University's Lewis Katz School of Medicine will present topics including advances, new technologies and issues in comprehensive stroke and neurological care.

Topics and presenters include, but are not limited to:

Thursday, September 8

8 a.m. - 9 a.m. – Evaluation and Management of Patent Foramen Ovale in the Acute Stroke Patient
Christopher L. Cummings, MD, interim Stroke Program director, Geisinger Health System, will discuss Patent Foramen Ovale (PFO) – or a hole in the heart – and its relationship to cryptogenic stroke, also known as stroke of unknown origin. This is an area of stroke care that is evolving rapidly, and there are differing opinions on the optimal management when PFO is discovered in a patient with cryptogenic stroke.

9 a.m. - 10 a.m. – Updates in Outpatient Care for the Transient Ischemic Attack Patient
Neil R. Holland, MD, FAAN, director of Neurology, Geisinger Health System, will discuss updates in outpatient care for the transient ischemic attack patient. Transient ischemic attack – often labeled as a "mini-stroke" – can be a warning sign for impending stroke and has traditionally led to an emergency hospital admission for further evaluation and intervention. Holland will share his research that shows these patients could be just as effectively evaluated in an open-access outpatient urgent care clinic.

10:15 a.m. - 11:15 a.m. – Updates in Endovascular Surgical Management of Cerebral Aneurysms
Pascal Jabbour, MD, associate professor, Department of Neurological Surgery, and chief, Division of Neurovascular Surgery and Endovascular Neurosurgery, Thomas Jefferson University Hospital, will discuss new techniques for endovascular treatment of brain aneurysm, along with the indications and limitations of such; and risks and benefits.

11:15 a.m. - 11:45 a.m. – Telemedicine: Innovations: Beyond the Routine Consult
Guiliana Labella, RN, BA, BSN, outreach coordinator, Jefferson Neuroscience Network and Vickie and Jack Farber Institute for Neuroscience at Jefferson, will discuss innovations in telemedicine that help give patients access to specialty care when they need it most. Over the years, innovative ways to use telehealth have evolved, allowing patients and healthcare providers to be instantly connected regardless of geographic boundaries. Labella will discuss how telehealth is on the forefront of medicine – from education to specialized ICU care.

12:30 p.m. - 1 p.m. – Being On the Other Side: A Neuro Critical Care Provider's Survivor Story
Joseph Drogo, APN, RN, AtlantiCare Regional Medical Center, Neuro Critical Care, will provide a personal testimonial of his own survivor's story. Drogo will discuss his own series of personal events, having suffered from a traumatic brain injury, and the importance of provider compassion and how that affects personal lives and outcomes.

1 p.m. - 2 p.m. – Updates in Medical Management for the Intracerebral Hemorrhage Patient in the Neuro Critical Care Setting
Edward Hamaty, DO, FACCP, FACOI, chairman, Critical Care, medical director, Neuro Critical Care, AtlantiCare Regional Medical Center, and assistant professor of Medicine, Rowan School of Osteopathic Medicine, will review how common brain tissue bleeds are; the risk factors to having one; and the diagnosis and treatment of them. Hamaty will give special attention to those areas under active investigation, including the correct level of blood pressure control, the role of inflammation in the incidence of bleed expansion, and new treatment options.

2 p.m. - 2:30 p.m. – The New Drip and Ship Model: Procoagulant Reversal Agents for the Intracerebral Hemorrhage Patient
Anthony Macchiavelli, MD, medical director, Hospitalist Program, AtlantiCare Regional Medical Center, will address the current state of anticoagulation reversal in patients with potentially life threatening bleeding. Many people find themselves on medications that are necessary for treating medical conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. While these medications, called anticoagulants (blood thinners), have clear benefit, there is also a risk associated with bleeding. Macchiavelli will discuss a new treatment era for these conditions, as well as the treatment of bleeding complications. Delays in reversing these anticoagulants can be devastating with a significant increase in morbidity and mortality in patients.

2:45 p.m. - 3:45 p.m. – Updates in Brain Tumor Research and Treatment
Christopher J. Farrell, MD, assistant professor, Department of Neurological Surgery, Thomas Jefferson University, Division of Neuro-Oncology, will discuss the most recent advances in the management of brain tumors, including advances in surgical, chemotherapeutic, and alternative therapies. He will also discuss the potential role of cellular telephone usage in the formation of malignant and benign brain tumors.

3:45 p.m. - 4:45 p.m. – Updates on Skull Base Approaches and Radiosurgery for Brain Tumors
Jorge Eller, MD, director of Endovascular Neurosurgeon and Stroke, Jefferson Neurosurgical Associates at AtlantiCare Regional Medical Center, will focus on the treatment of brain tumors. Eller will discuss new surgical techniques, including minimally invasive approaches for surgical removal of brain tumors, including at AtlantiCare. He will also emphasize AtlantiCare's multidisciplinary team and the different expertise that the team brings together in the care of patients with brain tumors, including skull base, otolaryngology, medical oncology and radiation oncology. Additionally, Eller will describe AtlantiCare's CyberKnife radiosurgery unit and the treatment options available that do not require open surgery.

Friday, September 9

7 a.m. - 8 a.m. – Updates in Endovascular Surgical Management of Arteriovenous Malformations
David Stidd, MD, endovascular neurosurgeon, Jefferson Neurosurgical Associates at ARMC, will discuss the pathology and epidemiology of arteriovenous malformations (AVMs) – or defects in arteries, veins, and capillaries – and common presentations of AVMs. Stidd will examine in detail the merits of different treatment strategies, including observation versus intervention.

8 a.m. - 9 a.m. – Updates in Endovascular Treatment for the Acute Stroke Patient: New Devices, Imaging Use, and Selection Criteria
Pinakin Jethwa, MD, general and endovascular neurosurgeon, Atlantic Neuro Surgical Specialists, will discuss the latest devices available for patients with acute stroke and the results of recent trials showing their efficacy. Jethwa will showcase examples of patients who have benefited from stroke intervention and will highlight how advanced imaging helps identify those patients who are likely to have a good outcome. Jethwa will conclude the presentation by highlighting future trends in stroke care.

9:15 a.m. - 10:15 a.m. – Pediatric Epilepsy Syndromes and the Emergent Treatment of Pediatric Seizures
Marissa DiGiovine, MD, pediatric neurologist, The Children's Hospital of Philadelphia Newborn and Pediatric Care at AtlantiCare, will discuss how to identify and treat common epilepsy syndromes in children. In addition, DiGiovine will discuss when and how to treat seizures emergently, as well as the pathway The Children's Hospital of Philadelphia uses to treat prolonged seizures (status epilepticus).

10:15 a.m. - 11:15 a.m. – Spine Deformity in the Adult Patient Population
Zeeshan Sardar, MD, spine surgeon, and assistant professor, Department of Orthopaedic Surgery & Sports Medicine, Temple University, Lewis Katz School of Medicine, will provide an introduction to the range of spinal deformities in adult patients. Sardar will discuss the symptoms and disability these conditions can cause, as well as updates in the treatment of patients with spinal deformities.

11:30 a.m. - 12:30 p.m. – ICU and Blood Pressure Management of Spinal Cord Injury Patients
Kris Radcliff, MD, spine surgeon, Rothman Institute at AtlantiCare, and associate professor, Thomas Jefferson University Hospital, will share how he and his colleagues at Rothman Institute have made significant scientific research contributions to the care of spinal-cord-injured patients. The presentation will review the recent innovations in spinal cord injury research and to cover how he and his team have used their research to help patients with spinal cord injury at AtlantiCare.

About the AtlantiCare Neurosciences Institute
AtlantiCare's Neurosciences Institute is based at AtlantiCare Regional Medical Center Atlantic City Campus. The team uses the most advanced technology to diagnose and treat
stroke and stroke-like syndromes and other neurological disorders of the brain and spine 24 hours a day, seven days a week. The New Jersey Department of Health and Senior Services has designated ARMC City Campus, Atlantic City, a comprehensive stroke center, and ARMC Mainland Campus, Pomona, a primary stroke center. AtlantiCare Regional Medical Center has earned the Gold Seal of Approval™ from The Joint Commission for Primary Stroke Centers.

About the Jefferson Neuroscience Network
The AtlantiCare Neurosciences Institute at ARMC is a member of the Jefferson Neuroscience Network. Through this collaboration, Jefferson and ARMC provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases. ARMC Atlantic City Campus is a comprehensive stroke center, utilizing leading-edge clinical protocols for the detection and treatment of stroke and other neuroscience disorders, and has access to the latest clinical trials.

For more information about ARMC's sixth annual Regional Neurosciences Conference and Stroke Summit, or other AtlantiCare programs and services, call the AtlantiCare Access Center at 1-888-569-1000, visit www.atlanticare.org or find AtlantiCare on Facebook at www.facebook.com/atlanticare.
Contacts:
Jennifer Tornetta, (O) 609-569-7010, (C) 609-335-3446, jennifer.tornetta@atlanticare.org 
Betsy Woerner, (O) 609-748-7539, (C) 609-385-6361, betsy.woerner@atlanticare.org 

-30-
_________________________________________________________________________________

AtlantiCare, a member of Geisinger Health System, is an integrated system of services designed to help people achieve optimal health. It includes AtlantiCare Regional Medical Center, AtlantiCare Health Engagement, the AtlantiCare Foundation, and AtlantiCare Health Services. Its more than 5,400 employees and more than 700 physicians serve the community in nearly 70 locations. A 2009 Malcolm Baldrige Award winner, AtlantiCare was also included in Modern Healthcare's Best Places to Work in Healthcare in 2010. ARMC became the 105th hospital in the nation to attain status as a Magnet™ designated hospital in March of 2004 and was redesignated a Magnet™ hospital in 2008 and 2013.